The launch of Septodont’s Biodentine XP pairs new levels of convenience with all the benefits of familiarity.
Cologne provided a perfect backdrop for one of the world’s leading dental manufacturers to reveal its latest restorative innovation.
Septodont’s Biodentine XP is an overhaul of the company’s successful full dentine replacement system – shaped by the lessons learned from the original iteration. Even the ‘XP’ name is a nod to Septodont’s improved experience with and understanding of patients’ needs.
So it may come as a surprise to find out that the material itself has not changed. It’s still the same all-in-one biocompatible, bioactive dentine substitute that has been winning fans for over 10 years.
Rather, the focus in Septodont’s Biodentine XP is on delivering a much more user-friendly, intuitive process.
Septodont Biodentine XP – experience in action
The dentine replacement material can now be delivered directly into the patient’s mouth. It comes in ready-mixed cartridges supported by a dedicated high-speed mixing unit that helps get the perfect consistency.
Septodont Biodentine XP users have a choice of two volumes. The XP200 is a smaller dose designed for pulp capping, small restorations and endodontic indications, while the larger XP500 is ideal for deep caries, bulk filling and quadrant restorations.
‘Biodentine is an extraordinary product that was launched in 2010,’ said Jérôme Haas, Septodont senior director of global marketing. ‘It really piqued the interest of the scientific dental community.
‘Septodont’s Biodentine XP has all the science of Biodentine embedded into a system that offers dental practitioners the experience they can expect.’
The material is suitable for 10 indications across both crown and root restorations.
Embracing a synthetic future
The show also saw the launch of a brand-new membrane from Septodont. The RTR+ Membrane is a novel, synthetic membrane developed intended for guided tissue regeneration (GTR) and guided bone regeneration (GBR).
This bi-layer synthetic membrane is fully resorbable within four to six months, providing ideal conditions for bone regeneration.
Bur critically, it is insensitive to saliva enzymes – meaning that should sutures rupture, the membrane can be left in to maintain the graft and guide tissue healing.
‘We strongly believe that the future [of membranes] is synthetic’, added Jérôme Haas, Septodont senior director of global marketing.
‘This avoids all questions that come up over products of animal origin because of religious or ethical concerns. It also means that cross contamination is not on the table.’
For more information visit www.septodont.co.uk.
